Dr. Steven R. Beach's lab at the University of Georgia focuses on understanding the factors that affect Alzheimer's disease, particularly among African Americans who are often underrepresented in research. The lab investigates how social, economic, and genetic factors influence the biomarkers related to Alzheimer's, using a long-term study that tracks families over many years. They aim to identify ways to improve health trajectories and potentially mitigate the impact of Alzheimer's disease in vulnerable populations.

Dr. Michael P Terns' lab focuses on understanding how bacteria defend themselves against viruses using CRISPR-Cas systems and how viruses counter these defenses. They study the molecular mechanisms behind these interactions to enhance CRISPR technologies for medical applications. The ultimate goal is to apply this knowledge to improve tools for gene editing, disease diagnosis, and combating antibiotic resistance.

Dr. Yaguang Xi's lab at the University of Georgia focuses on developing new therapies for difficult-to-treat breast cancer, particularly triple-negative breast cancer (TNBC). They are investigating a new compound called LG007, which has shown promise in shrinking tumors and inhibiting cancer spread in preclinical models. The lab combines molecular biology techniques with advanced animal models to understand the drug's actions and prepare for possible clinical trials.

Dr. Jin Xie's lab at the University of Georgia focuses on enhancing cancer treatment by using advanced technology to improve the response of the immune system to tumors. Specifically, the lab is developing calcium nanoparticles that can help immune cells called dendritic cells migrate to tumors more effectively, which could make therapies combining radiation and immune treatment more successful. Their research aims to better understand and manipulate immune responses to improve outcomes for cancer patients.

Dr. Silvia N. Moreno's research lab focuses on understanding how the Toxoplasma gondii parasite uses calcium signaling for infection and survival. They aim to identify new drug targets to combat reactivation of this common parasite that poses severe risks to immunocompromised individuals and pregnant women. By uncovering the mechanisms of calcium channels and other critical pathways, the lab is working towards developing more effective treatments for toxoplasmosis.

Dr. Rick L Tarleton's lab focuses on improving diagnostics and treatment strategies for Chagas disease, caused by the parasite Trypanosoma cruzi. By developing more sensitive detection methods using advanced PCR techniques, the lab aims to enhance understanding of the parasite's lifecycle and effectively monitor treatment outcomes in both humans and animals, particularly dogs. This research addresses a major health challenge in Latin America and aims to improve public health interventions.

Dr. Karl F. Lechtreck's lab focuses on understanding how the tiny hair-like structures on cells, called cilia, are assembled and how they transport proteins critical for their function. Cilia play important roles in cell movement and signaling, and problems with cilia can lead to health issues like blindness or infertility. By exploring the mechanisms of protein transport in cilia using a simple model organism, the lab aims to shed light on these vital cellular processes which have wider implications for human health.

Dr. David Crich's lab focuses on developing next-generation aminoglycoside antibiotics that are effective against multidrug-resistant bacteria while minimizing side effects like hearing loss and kidney damage. By synthesizing and optimizing new compounds, the lab aims to create more effective treatments with improved safety profiles. Research includes a combination of laboratory assays and animal models to test efficacy and toxicity.

Dr. Cynthia Suveg's lab at the University of Georgia focuses on understanding how physiological stress regulation in Latin American children affects their academic and behavioral outcomes. The research aims to identify protective factors within families, particularly parenting practices, that help mitigate these challenges. Through a culturally informed lens, the lab seeks to provide insights that can lead to effective interventions to support Latin American families and enhance child development during early childhood.

Dr. Gregory P. Strauss's lab at the University of Georgia focuses on understanding and improving emotion regulation in individuals with psychotic disorders. They are investigating whether a novel cognitive training program, delivered through a smartphone app, can enhance brain function and alleviate difficulties with managing emotions. Their work aims to create a more effective and accessible treatment for mental health challenges associated with these disorders.

Dr. Richard Brian Meagher's lab focuses on tackling invasive fungal diseases that pose serious health risks, particularly in immunocompromised patients. The lab has developed a novel drug delivery system using targeted liposomes that can improve the effectiveness of antifungal treatments, significantly enhancing their ability to combat infections caused by fungi such as Candida albicans and Aspergillus fumigatus. Their research aims to create substantial improvements in antifungal therapies, potentially saving many lives.

Dr. Michael Stephen Trent's lab at the University of Georgia focuses on understanding how Gram-negative bacteria, like Acinetobacter baumannii, develop their protective outer membrane. The research aims to uncover the mechanisms behind the transport and assembly of essential membrane components, which is crucial due to the rising threat of antibiotic resistance. The findings could lead to innovative strategies for designing new antimicrobial treatments that target these formidable pathogens.

Dr. Arthi Kanthasamy's research lab focuses on understanding how neuroinflammation contributes to Parkinson's disease and related disorders. The lab studies a specific protein, called 'ALKBH5', which plays a role in how immune cells in the brain respond to nerve injury. By investigating the mechanisms of inflammation and cellular signaling processes, the lab aims to develop new therapeutic strategies to treat neurodegenerative diseases.

Dr. Vasant Muralidharan's lab at the University of Georgia focuses on understanding how a malaria-causing parasite, Plasmodium falciparum, modifies its proteins to survive and thrive inside human red blood cells. His research investigates the unique ways this parasite traffics proteins without using common eukaryotic mechanisms, aiming to uncover potential targets for new antimalarial therapies. This work is crucial given the rising drug resistance among malaria parasites.

Dr. Jason R. Richardson's lab at the University of Georgia focuses on understanding how microglial cells, which are the brain's immune defenders, contribute to neuroinflammation and diseases like Parkinson's. The lab is particularly interested in a specific proton channel called Hv1 and how its activity influences the brain's response to toxic substances like paraquat, a common herbicide. By delving into the mechanisms behind these processes, the goal is to discover new therapeutic strategies that could help slow down or prevent neurodegenerative diseases.

Dr. Frederick D. Quinn's lab at the University of Georgia focuses on developing novel vaccines to combat respiratory infections, particularly tuberculosis. Using advanced nanoparticle technology, the lab is researching ways to stimulate local immune responses in the lungs to provide better protection against diseases caused by inhaled pathogens. By combining multiple mycobacterial proteins with immune-boosting components, they aim to create a more effective vaccine that builds on existing methods.

Dr. Xiaorong Lin's lab focuses on developing a vaccine for cryptococcal meningoencephalitis, a severe fungal infection that is particularly dangerous for people with HIV/AIDS. The lab studies the life cycle of the fungus Cryptococcus neoformans, specifically its transition between different forms, to understand how it interacts with the immune system. By harnessing unique immunogenic properties of the fungus, the lab aims to create effective vaccines that can provide protection even for individuals with weakened immune systems.

Dr. Jorge C Escalante's lab at the University of Georgia focuses on understanding how prokaryotic cells, like bacteria, manage their metabolism to adapt to different environments, including during infections. The lab studies specific enzymes that modify other proteins and examines the complex process of making a large coenzyme essential for microbial life. They use advanced techniques to visualize these intricate molecular structures and aim to uncover new therapeutic targets for human diseases related to microbial infections.

Dr. Xiaoqin Ye's research lab at the University of Georgia focuses on understanding how the uterus regulates fluid absorption during early pregnancy. This research is particularly important for improving fertility treatments, especially for women experiencing issues with embryo implantation. By studying both mouse models and human tissue samples, the lab aims to uncover the hormonal and cellular mechanisms involved in uterine fluid dynamics, which can significantly impact pregnancy outcomes.